Paul Matteis
Stock Analyst at Stifel Nicolaus
(4.83)
# 473
Out of 4,683 analysts
738
Total ratings
53.5%
Success rate
18.1%
Average return
Main Sectors:
Stocks Rated by Paul Matteis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTNM Contineum Therapeutics | Maintained: Buy | $28 | $17.02 | +64.51% | 11 | Aug 14, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $318 | $239.00 | +33.05% | 49 | Aug 13, 2026 | |
| QURE uniQure | Maintained: Buy | $71 | $50.95 | +39.35% | 27 | Aug 13, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $46 | $38.41 | +19.76% | 25 | Aug 13, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $86 | $63.79 | +34.82% | 29 | Aug 13, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $21 | $14.61 | +43.74% | 8 | Aug 13, 2026 | |
| PEPG PepGen | Maintained: Buy | $12 | $3.22 | +272.67% | 18 | Aug 13, 2026 | |
| RAPP Rapport Therapeutics | Maintained: Buy | $56 | $52.50 | +6.67% | 11 | Aug 13, 2026 | |
| LBRX LB Pharmaceuticals | Maintained: Buy | $40 → $53 | $48.17 | +10.04% | 4 | Aug 13, 2026 | |
| SPTX Seaport Therapeutics | Maintained: Buy | $30 | $27.90 | +7.53% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $65.61 | +6.69% | 46 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $7 | $6.17 | +13.45% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $500 | $547.29 | -8.64% | 43 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $43.77 | +37.08% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $24.57 | +66.87% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $38 | $29.01 | +30.99% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $29.58 | -15.48% | 51 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $214 → $242 | $221.07 | +9.47% | 52 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 → $68 | $63.36 | +7.32% | 33 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $188 → $215 | $156.59 | +37.30% | 55 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $37 | $26.36 | +40.36% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $49.16 | +28.15% | 59 | Jul 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.26 | +284.62% | 8 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $5.01 | +239.32% | 9 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $111.87 | +18.89% | 12 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $36 | $12.86 | +179.94% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $16.49 | +51.61% | 3 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.56 | +92.31% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $36.53 | -9.66% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.46 | - | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.99 | +234.45% | 9 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.81 | n/a | 11 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $16.08 | n/a | 11 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $5.23 | n/a | 13 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $20 | $82.67 | n/a | 4 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.0001 | n/a | 1 | Aug 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $20 | $0.0001 | n/a | 4 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.85 | n/a | 1 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.57 | n/a | 4 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $17.03 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.0001 | n/a | 3 | May 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $7 | $1.08 | n/a | 2 | May 6, 2016 |
Contineum Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $28
Current: $17.02
Upside: +64.51%
Alnylam Pharmaceuticals
Aug 13, 2026
Maintained: Buy
Price Target: $318
Current: $239.00
Upside: +33.05%
uniQure
Aug 13, 2026
Maintained: Buy
Price Target: $71
Current: $50.95
Upside: +39.35%
Neurogene
Aug 13, 2026
Reiterated: Buy
Price Target: $46
Current: $38.41
Upside: +19.76%
Xenon Pharmaceuticals
Aug 13, 2026
Maintained: Buy
Price Target: $86
Current: $63.79
Upside: +34.82%
COMPASS Pathways
Aug 13, 2026
Maintained: Buy
Price Target: $21
Current: $14.61
Upside: +43.74%
PepGen
Aug 13, 2026
Maintained: Buy
Price Target: $12
Current: $3.22
Upside: +272.67%
Rapport Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $56
Current: $52.50
Upside: +6.67%
LB Pharmaceuticals
Aug 13, 2026
Maintained: Buy
Price Target: $40 → $53
Current: $48.17
Upside: +10.04%
Seaport Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $30
Current: $27.90
Upside: +7.53%
Aug 11, 2026
Maintained: Hold
Price Target: $70
Current: $65.61
Upside: +6.69%
Aug 10, 2026
Downgraded: Hold
Price Target: $55 → $7
Current: $6.17
Upside: +13.45%
Aug 9, 2026
Maintained: Hold
Price Target: $500
Current: $547.29
Upside: -8.64%
Aug 7, 2026
Reiterated: Buy
Price Target: $60
Current: $43.77
Upside: +37.08%
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $24.57
Upside: +66.87%
Aug 6, 2026
Maintained: Buy
Price Target: $32 → $38
Current: $29.01
Upside: +30.99%
Aug 5, 2026
Maintained: Hold
Price Target: $25
Current: $29.58
Upside: -15.48%
Aug 2, 2026
Maintained: Buy
Price Target: $214 → $242
Current: $221.07
Upside: +9.47%
Aug 2, 2026
Maintained: Hold
Price Target: $86 → $68
Current: $63.36
Upside: +7.32%
Jul 31, 2026
Maintained: Buy
Price Target: $188 → $215
Current: $156.59
Upside: +37.30%
Jul 31, 2026
Maintained: Buy
Price Target: $36 → $37
Current: $26.36
Upside: +40.36%
Jul 25, 2026
Maintained: Buy
Price Target: $63
Current: $49.16
Upside: +28.15%
Jul 6, 2026
Maintained: Hold
Price Target: $1
Current: $0.26
Upside: +284.62%
Jul 6, 2026
Maintained: Buy
Price Target: $17
Current: $5.01
Upside: +239.32%
Jun 15, 2026
Reiterated: Buy
Price Target: $133
Current: $111.87
Upside: +18.89%
Jun 2, 2026
Reiterated: Buy
Price Target: $28 → $36
Current: $12.86
Upside: +179.94%
May 28, 2026
Maintained: Buy
Price Target: $25
Current: $16.49
Upside: +51.61%
May 12, 2026
Maintained: Hold
Price Target: $3
Current: $1.56
Upside: +92.31%
Apr 2, 2026
Maintained: Buy
Price Target: $33
Current: $36.53
Upside: -9.66%
Dec 22, 2025
Rated: Hold
Price Target: n/a
Current: $2.46
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $10
Current: $2.99
Upside: +234.45%
Sep 19, 2024
Rated: Hold
Price Target: n/a
Current: $7.81
Upside: n/a
Jun 3, 2023
Maintained: Buy
Price Target: $5
Current: $16.08
Upside: n/a
May 12, 2022
Reiterated: Hold
Price Target: $3
Current: $5.23
Upside: n/a
Feb 28, 2022
Downgraded: Hold
Price Target: $11 → $20
Current: $82.67
Upside: n/a
Aug 16, 2017
Initiated Coverage: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $14 → $20
Current: $0.0001
Upside: n/a
Nov 23, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.85
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.57
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: $29
Current: $17.03
Upside: n/a
May 19, 2016
Maintained: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
May 6, 2016
Reiterated: Hold
Price Target: $14 → $7
Current: $1.08
Upside: n/a